Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation

RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases....

Full description

Saved in:
Bibliographic Details
Published inCirculation research Vol. 119; no. 2; pp. 222 - 236
Main Authors Wang, Yi-Fu, Hsu, Yu-Juei, Wu, Hsu-Feng, Lee, Guan-Lin, Yang, Ya-Sung, Wu, Jing-Yiing, Yet, Shaw-Fang, Wu, Kenneth K., Kuo, Cheng-Chin
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 08.07.2016
Subjects
Online AccessGet full text
ISSN0009-7330
1524-4571
1524-4571
DOI10.1161/CIRCRESAHA.116.308559

Cover

Loading…
Abstract RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation. OBJECTIVE:To identify endothelial cell–released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation. METHODS AND RESULTS:We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography–mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell–derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture–mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance. CONCLUSIONS:We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses.
AbstractList Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation.RATIONALESystemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation.To identify endothelial cell-released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation.OBJECTIVETo identify endothelial cell-released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation.We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography-mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell-derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture-mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance.METHODS AND RESULTSWe found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography-mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell-derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture-mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance.We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses.CONCLUSIONSWe conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses.
RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation. OBJECTIVE:To identify endothelial cell–released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation. METHODS AND RESULTS:We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography–mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell–derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture–mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance. CONCLUSIONS:We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses.
Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical in maintaining cellular and inflammatory homeostasis, controlling systemic inflammation, and progression of inflammatory diseases. We postulated that endothelium produces and releases endogenous soluble factors to modulate inflammatory responses and protect against systemic inflammation. To identify endothelial cell-released soluble factors that protect against endothelial barrier dysfunction and systemic inflammation. We found that conditioned medium of endothelial cells inhibited cyclooxgenase-2 and interleukin-6 expression in macrophages stimulated with lipopolysaccharide. Analysis of conditioned medium extracts by liquid chromatography-mass spectrometry showed the presence of 5-methoxytryptophan (5-MTP), but not other related tryptophan metabolites. Furthermore, endothelial cell-derived 5-MTP suppressed lipopolysaccharide-induced inflammatory responses and signaling in macrophages and endotoxemic lung tissues. Lipopolysaccharide suppressed 5-MTP level in endothelial cell-conditioned medium and reduced serum 5-MTP level in the murine sepsis model. Intraperitoneal injection of 5-MTP restored serum 5-MTP accompanied by the inhibition of lipopolysaccharide-induced endothelial leakage and suppression of lipopolysaccharide- or cecal ligation and puncture-mediated proinflammatory mediators overexpression. 5-MTP administration rescued lungs from lipopolysaccharide-induced damages and prevented sepsis-related mortality. Importantly, compared with healthy subjects, serum 5-MTP level in septic patients was decreased by 65%, indicating an important clinical relevance. We conclude that 5-MTP belongs to a novel class of endothelium-derived protective molecules that defend against endothelial barrier dysfunction and excessive systemic inflammatory responses.
Author Yet, Shaw-Fang
Yang, Ya-Sung
Wang, Yi-Fu
Lee, Guan-Lin
Wu, Hsu-Feng
Wu, Kenneth K.
Hsu, Yu-Juei
Kuo, Cheng-Chin
Wu, Jing-Yiing
AuthorAffiliation From the Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan (Y.-F.W., H.-F.W., G.-L.L., J.-Y.W., S.-F.Y., K.K.W., C.-C.K.); Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan (Y.-F.W.); Division of Nephrology (Y.-J.H.), Division of Infectious Diseases and Tropical Medicine (Y.-S.Y.), Department of Medicine, Tri-Service General Hospital (Y.-J.H., Y.-S.Y.), and Graduate Institutes of Life Sciences and Biochemistry (Y.-J.H., G.-L.L., Y.-S.Y., C.-C.K.), National Defense Medical Center, Taipei, Taiwan; Metabolomic Research Center, China Medical University Hospital (S.-F.Y., K.K.W., C.-C.K.) and Graduate Institute of Basic Medical Science (S.-F.Y., K.K.W., C.-C.K.), China Medical University, Taichung, Taiwan; and Department of Medicine, University of Texas, Houston (K.K.W.)
AuthorAffiliation_xml – name: From the Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan (Y.-F.W., H.-F.W., G.-L.L., J.-Y.W., S.-F.Y., K.K.W., C.-C.K.); Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan (Y.-F.W.); Division of Nephrology (Y.-J.H.), Division of Infectious Diseases and Tropical Medicine (Y.-S.Y.), Department of Medicine, Tri-Service General Hospital (Y.-J.H., Y.-S.Y.), and Graduate Institutes of Life Sciences and Biochemistry (Y.-J.H., G.-L.L., Y.-S.Y., C.-C.K.), National Defense Medical Center, Taipei, Taiwan; Metabolomic Research Center, China Medical University Hospital (S.-F.Y., K.K.W., C.-C.K.) and Graduate Institute of Basic Medical Science (S.-F.Y., K.K.W., C.-C.K.), China Medical University, Taichung, Taiwan; and Department of Medicine, University of Texas, Houston (K.K.W.)
Author_xml – sequence: 1
  givenname: Yi-Fu
  surname: Wang
  fullname: Wang, Yi-Fu
  organization: From the Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan (Y.-F.W., H.-F.W., G.-L.L., J.-Y.W., S.-F.Y., K.K.W., C.-C.K.); Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan (Y.-F.W.); Division of Nephrology (Y.-J.H.), Division of Infectious Diseases and Tropical Medicine (Y.-S.Y.), Department of Medicine, Tri-Service General Hospital (Y.-J.H., Y.-S.Y.), and Graduate Institutes of Life Sciences and Biochemistry (Y.-J.H., G.-L.L., Y.-S.Y., C.-C.K.), National Defense Medical Center, Taipei, Taiwan; Metabolomic Research Center, China Medical University Hospital (S.-F.Y., K.K.W., C.-C.K.) and Graduate Institute of Basic Medical Science (S.-F.Y., K.K.W., C.-C.K.), China Medical University, Taichung, Taiwan; and Department of Medicine, University of Texas, Houston (K.K.W.)
– sequence: 2
  givenname: Yu-Juei
  surname: Hsu
  fullname: Hsu, Yu-Juei
– sequence: 3
  givenname: Hsu-Feng
  surname: Wu
  fullname: Wu, Hsu-Feng
– sequence: 4
  givenname: Guan-Lin
  surname: Lee
  fullname: Lee, Guan-Lin
– sequence: 5
  givenname: Ya-Sung
  surname: Yang
  fullname: Yang, Ya-Sung
– sequence: 6
  givenname: Jing-Yiing
  surname: Wu
  fullname: Wu, Jing-Yiing
– sequence: 7
  givenname: Shaw-Fang
  surname: Yet
  fullname: Yet, Shaw-Fang
– sequence: 8
  givenname: Kenneth
  surname: Wu
  middlename: K.
  fullname: Wu, Kenneth K.
– sequence: 9
  givenname: Cheng-Chin
  surname: Kuo
  fullname: Kuo, Cheng-Chin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27151398$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1P3DAQhi1EBcvCT6DysZdQO47zoZ626QIrgSrtwjlynEnj4thb2ynk35PtUir1sidr7OexZuY9Q8fGGkDokpIrSlP6uVyty_Vys7hd7OorRnLOiyM0ozxOooRn9BjNCCFFlDFGTtGZ9z8JoQmLixN0GmeUU1bkMzQsTWNDB1oNffQNnPoNDebRPYTOvozBjdtgt50weOWxwKVyctAiKPMDL0xQ0cq0WvS9CNaN-N5qmJ4BP3Qi4K_ayiePN6MP0CuJ31FlzTn60Art4eLtnKPH6-VDeRvdfb9ZlYu7SCYknVpPJTRZnIs6qVvRxi0FLvLplhRNS2WSMZjApJY85m3NGp6nkuXT0LFkRIiczdGn_b9bZ38N4EPVKy9Ba2HADr6iOYmzhFKeTujHN3Soe2iqrVO9cGP1d1UTwPeAdNZ7B-07Qkm1i6T6F8murvaRTN6X_zypwp8tBCeUPmgXe_vZ6gDOP-nhGVzVgdChO-C-AqUHpjM
CitedBy_id crossref_primary_10_1186_s12929_020_00671_w
crossref_primary_10_18632_aging_102350
crossref_primary_10_1074_jbc_RA117_000597
crossref_primary_10_1186_s12896_024_00890_1
crossref_primary_10_3390_ijms22094490
crossref_primary_10_3390_ijms17091394
crossref_primary_10_1016_j_yjmcc_2021_05_014
crossref_primary_10_1097_MOH_0000000000000848
crossref_primary_10_1038_s41598_017_11077_4
crossref_primary_10_1039_D3FO01831H
crossref_primary_10_1038_s41598_018_25015_5
crossref_primary_10_1007_s00726_020_02878_5
crossref_primary_10_1007_s10753_016_0464_6
crossref_primary_10_1161_CIRCRESAHA_116_309122
crossref_primary_10_1016_j_molcel_2019_10_023
crossref_primary_10_1097_IMNA_D_24_00019
crossref_primary_10_1016_j_lfs_2020_118399
crossref_primary_10_1186_s12929_021_00771_1
crossref_primary_10_5847_wjem_j_1920_8642_2023_019
crossref_primary_10_1007_s12265_024_10518_6
crossref_primary_10_3390_ijms22020697
crossref_primary_10_3389_fimmu_2023_1300378
crossref_primary_10_1080_0886022X_2024_2409346
crossref_primary_10_3389_fped_2022_828968
crossref_primary_10_1161_RES_0000000000000152
crossref_primary_10_1186_s13765_022_00705_x
crossref_primary_10_1016_j_jmii_2018_12_003
crossref_primary_10_3390_ijms20246115
crossref_primary_10_1016_j_freeradbiomed_2022_06_235
crossref_primary_10_30683_1927_7229_2021_10_01
crossref_primary_10_1016_j_heliyon_2023_e19501
crossref_primary_10_1016_j_freeradbiomed_2021_01_040
crossref_primary_10_3389_fimmu_2023_1072810
crossref_primary_10_1155_2017_8314276
crossref_primary_10_1177_2040622320962648
crossref_primary_10_1038_s41522_024_00631_4
crossref_primary_10_3390_cancers13215311
crossref_primary_10_1159_000543275
crossref_primary_10_1021_acscombsci_9b00050
crossref_primary_10_1038_s41467_019_09329_0
crossref_primary_10_1016_j_intimp_2020_106988
crossref_primary_10_1016_j_jchromb_2018_01_008
crossref_primary_10_1007_s12272_016_0809_6
crossref_primary_10_3390_ijms23147548
crossref_primary_10_1161_JAHA_123_029785
crossref_primary_10_2337_db22_0095
crossref_primary_10_1016_j_ijcard_2016_12_154
crossref_primary_10_1007_s00011_023_01769_1
crossref_primary_10_1039_D4FO02039A
crossref_primary_10_1080_15384101_2021_1897241
crossref_primary_10_2147_JIR_S474040
crossref_primary_10_1186_s13071_023_05881_3
crossref_primary_10_1016_j_ijcard_2016_12_151
crossref_primary_10_1371_journal_pone_0182707
crossref_primary_10_1002_tox_22749
crossref_primary_10_3389_fphar_2021_759199
crossref_primary_10_1016_j_heliyon_2024_e33309
crossref_primary_10_1016_j_chemosphere_2024_142615
crossref_primary_10_1038_s41598_020_63313_z
crossref_primary_10_3748_wjg_v29_i47_6148
crossref_primary_10_1155_2024_1484806
crossref_primary_10_1161_ATVBAHA_118_311874
crossref_primary_10_1210_clinem_dgae593
crossref_primary_10_1007_s00018_017_2504_2
crossref_primary_10_1038_s41598_024_82047_w
Cites_doi 10.1097/MPA.0000000000000270
10.1161/CIRCULATIONAHA.106.652859
10.1016/j.abb.2013.12.014
10.1074/jbc.R000025200
10.1189/jlb.0607373
10.1016/j.bbagrm.2013.04.007
10.1038/ni.2785
10.1046/j.1440-1711.2003.t01-1-01177.x
10.1186/2110-5820-1-17
10.1016/j.it.2012.05.002
10.1016/j.prostaglandins.2015.04.006
10.1038/nri2402
10.1182/blood-2005-09-3691
10.1016/j.jss.2008.04.030
10.1189/jlb.0105017
10.1074/jbc.M111.295113
10.1016/j.ajpath.2012.11.022
10.1159/000430785
10.1016/S0006-2952(03)00556-2
10.1038/nm0503-517
10.1124/pr.109.001073
10.1016/j.tem.2010.08.007
10.1038/nrd1854
10.1074/jbc.M209286200
10.1161/01.ATV.0000157899.35660.61
10.4049/jimmunol.171.12.6581
10.1016/j.thromres.2011.10.013
10.1073/pnas.1209919109
10.1155/2010/641865
10.1097/CCM.0b013e31828a44ed
10.4049/jimmunol.178.10.6100
10.4049/jimmunol.179.10.7101
10.1093/emboj/cdg139
10.1371/journal.pone.0088507
10.1161/01.cir.0000018127.10968.34
10.1084/jem.20101629
10.1074/jbc.275.9.6259
10.1038/nm.2092
10.1161/ATVBAHA.112.300302
10.1016/S0065-2776(08)60740-3
10.1038/nrd3793
10.1097/01.CCM.0000050454.01978.3B
10.1152/ajpregu.00858.2009
10.1111/j.1600-065X.2011.01088.x
10.1128/MCB.26.3.789-809.2006
10.1007/s10753-007-9027-1
ContentType Journal Article
Copyright 2016 American Heart Association, Inc.
Copyright_xml – notice: 2016 American Heart Association, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIRCRESAHA.116.308559
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4571
EndPage 236
ExternalDocumentID 27151398
10_1161_CIRCRESAHA_116_308559
10.1161/CIRCRESAHA.116.308559
Genre Journal Article
GroupedDBID ---
-~X
.-D
.3C
.Z2
01R
0R~
18M
1J1
29B
2WC
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACNWC
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BOYCO
BQLVK
C45
CS3
DIK
DIWNM
DU5
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
YFH
YOC
ZFV
ZZMQN
AAYXX
ADGHP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADSXY
ID FETCH-LOGICAL-c4069-76ced728ab4bfaf2f1e5a876c09df1c473ec404bc525fb3d586c380092c30aa83
ISSN 0009-7330
1524-4571
IngestDate Fri Sep 05 07:26:00 EDT 2025
Mon Jul 21 06:06:24 EDT 2025
Thu Apr 24 23:04:17 EDT 2025
Tue Jul 01 04:27:47 EDT 2025
Fri May 16 03:43:19 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords 5-methoxytryptophan
inflammation
sepsis
capillary permeability
shock
Language English
License 2016 American Heart Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4069-76ced728ab4bfaf2f1e5a876c09df1c473ec404bc525fb3d586c380092c30aa83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.116.308559
PMID 27151398
PQID 1802741156
PQPubID 23479
PageCount 15
ParticipantIDs proquest_miscellaneous_1802741156
pubmed_primary_27151398
crossref_primary_10_1161_CIRCRESAHA_116_308559
crossref_citationtrail_10_1161_CIRCRESAHA_116_308559
wolterskluwer_health_10_1161_CIRCRESAHA_116_308559
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-July-8
2016-07-08
2016-Jul-08
20160708
PublicationDateYYYYMMDD 2016-07-08
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-July-8
  day: 08
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation research
PublicationTitleAlternate Circ Res
PublicationYear 2016
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_5_28_2
e_1_3_5_27_2
e_1_3_5_26_2
e_1_3_5_25_2
e_1_3_5_24_2
e_1_3_5_23_2
e_1_3_5_22_2
e_1_3_5_21_2
e_1_3_5_43_2
e_1_3_5_44_2
e_1_3_5_45_2
e_1_3_5_46_2
e_1_3_5_47_2
e_1_3_5_29_2
e_1_3_5_2_2
e_1_3_5_40_2
e_1_3_5_41_2
e_1_3_5_42_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_7_2
e_1_3_5_9_2
e_1_3_5_4_2
e_1_3_5_3_2
e_1_3_5_6_2
e_1_3_5_5_2
e_1_3_5_17_2
e_1_3_5_39_2
e_1_3_5_16_2
e_1_3_5_38_2
e_1_3_5_15_2
e_1_3_5_37_2
e_1_3_5_14_2
e_1_3_5_36_2
e_1_3_5_12_2
e_1_3_5_35_2
e_1_3_5_13_2
e_1_3_5_34_2
e_1_3_5_10_2
e_1_3_5_33_2
e_1_3_5_11_2
e_1_3_5_32_2
e_1_3_5_19_2
e_1_3_5_18_2
e_1_3_5_31_2
e_1_3_5_30_2
27390326 - Circ Res. 2016 Jul 8;119(2):178-80
27587414 - Circ Res. 2016 Sep 2;119(6):e108
References_xml – ident: e_1_3_5_25_2
  doi: 10.1097/MPA.0000000000000270
– ident: e_1_3_5_22_2
  doi: 10.1161/CIRCULATIONAHA.106.652859
– ident: e_1_3_5_28_2
  doi: 10.1016/j.abb.2013.12.014
– ident: e_1_3_5_31_2
  doi: 10.1074/jbc.R000025200
– ident: e_1_3_5_2_2
  doi: 10.1189/jlb.0607373
– ident: e_1_3_5_30_2
  doi: 10.1016/j.bbagrm.2013.04.007
– ident: e_1_3_5_35_2
  doi: 10.1038/ni.2785
– ident: e_1_3_5_44_2
  doi: 10.1046/j.1440-1711.2003.t01-1-01177.x
– ident: e_1_3_5_4_2
  doi: 10.1186/2110-5820-1-17
– ident: e_1_3_5_11_2
  doi: 10.1016/j.it.2012.05.002
– ident: e_1_3_5_14_2
  doi: 10.1016/j.prostaglandins.2015.04.006
– ident: e_1_3_5_8_2
  doi: 10.1038/nri2402
– ident: e_1_3_5_24_2
  doi: 10.1182/blood-2005-09-3691
– ident: e_1_3_5_39_2
  doi: 10.1016/j.jss.2008.04.030
– ident: e_1_3_5_9_2
  doi: 10.1189/jlb.0105017
– ident: e_1_3_5_18_2
  doi: 10.1074/jbc.M111.295113
– ident: e_1_3_5_23_2
  doi: 10.1016/j.ajpath.2012.11.022
– ident: e_1_3_5_20_2
  doi: 10.1159/000430785
– ident: e_1_3_5_46_2
  doi: 10.1016/S0006-2952(03)00556-2
– ident: e_1_3_5_3_2
  doi: 10.1038/nm0503-517
– ident: e_1_3_5_10_2
  doi: 10.1124/pr.109.001073
– ident: e_1_3_5_41_2
  doi: 10.1016/j.tem.2010.08.007
– ident: e_1_3_5_6_2
  doi: 10.1038/nrd1854
– ident: e_1_3_5_27_2
  doi: 10.1074/jbc.M209286200
– ident: e_1_3_5_38_2
  doi: 10.1161/01.ATV.0000157899.35660.61
– ident: e_1_3_5_26_2
  doi: 10.4049/jimmunol.171.12.6581
– ident: e_1_3_5_5_2
  doi: 10.1016/j.thromres.2011.10.013
– ident: e_1_3_5_15_2
  doi: 10.1073/pnas.1209919109
– ident: e_1_3_5_13_2
  doi: 10.1155/2010/641865
– ident: e_1_3_5_40_2
  doi: 10.1097/CCM.0b013e31828a44ed
– ident: e_1_3_5_21_2
  doi: 10.4049/jimmunol.178.10.6100
– ident: e_1_3_5_42_2
  doi: 10.4049/jimmunol.179.10.7101
– ident: e_1_3_5_43_2
  doi: 10.1093/emboj/cdg139
– ident: e_1_3_5_16_2
  doi: 10.1371/journal.pone.0088507
– ident: e_1_3_5_29_2
  doi: 10.1161/01.cir.0000018127.10968.34
– ident: e_1_3_5_47_2
  doi: 10.1084/jem.20101629
– ident: e_1_3_5_37_2
  doi: 10.1074/jbc.275.9.6259
– ident: e_1_3_5_12_2
  doi: 10.1038/nm.2092
– ident: e_1_3_5_19_2
  doi: 10.1161/ATVBAHA.112.300302
– ident: e_1_3_5_36_2
  doi: 10.1016/S0065-2776(08)60740-3
– ident: e_1_3_5_45_2
  doi: 10.1038/nrd3793
– ident: e_1_3_5_17_2
  doi: 10.1097/01.CCM.0000050454.01978.3B
– ident: e_1_3_5_33_2
  doi: 10.1152/ajpregu.00858.2009
– ident: e_1_3_5_34_2
  doi: 10.1111/j.1600-065X.2011.01088.x
– ident: e_1_3_5_32_2
  doi: 10.1128/MCB.26.3.789-809.2006
– ident: e_1_3_5_7_2
  doi: 10.1007/s10753-007-9027-1
– reference: 27587414 - Circ Res. 2016 Sep 2;119(6):e108
– reference: 27390326 - Circ Res. 2016 Jul 8;119(2):178-80
SSID ssj0014329
Score 2.457589
Snippet RATIONALE:Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium...
Systemic inflammation has emerged as a key pathophysiological process that induces multiorgan injury and causes serious human diseases. Endothelium is critical...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 222
SubjectTerms Aged
Aged, 80 and over
Animals
Anti-Inflammatory Agents - blood
Endothelium, Vascular - metabolism
Endotoxemia - blood
Endotoxemia - prevention & control
Female
Human Umbilical Vein Endothelial Cells - metabolism
Humans
Inflammation - blood
Inflammation - prevention & control
Male
Mice
Mice, Inbred C57BL
Middle Aged
Tryptophan - analogs & derivatives
Tryptophan - blood
Title Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation
URI https://www.ncbi.nlm.nih.gov/pubmed/27151398
https://www.proquest.com/docview/1802741156
Volume 119
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwELfKkBAIId6Ul4zEt8qjifPqx6psagdFAnXS-BTZjj2ibenUJMD4g_g7uUucNFMrBvsStY7tRLmfz3fnexDy1kv8SHPpMpMEioH-ZZjAdeWEQga-UdyVaBqYfwqmh97BkX_U6_3ueC2VhdxVv7bGlVyHqtAGdMUo2f-gbDspNMBvoC9cgcJw_Sca72UJBlCdpuUZew8P_A7So8_mWBT650WxujjHrAGwgGf5QAwm6UpVtbrQDpIVKZtlBuBwVh-zz-syuXqw-IYmA9jiTnKbzjxVg7ZrQ8Umt0Ez5xKjYjqGscpEX7ORrynbL1v05GXVVrKDUqdt16oR7jH4vMdNq_URAhBn7KNNEG7tE05Q-bJGa0Q1B09TeIeiC7oNZ0-U91jI7TlNw50tR007WrLltXVAs9223TqPyuaOEOCOMJl9mQCix9Mxtuxy9M4brbfA1jHxihE3yE0X1BEsEfLh8_q0yuPuqKnYh-9vI8Vgondbp7ksA20oNnfI3R9L9JXIT6pQiY7As7hP7llNhY5r2D0gPZ09JLfm1hfjESm3oI9uQR-d5VTQDvroBvpogz6K6KM1-miDPtpF32NyuL-3mEyZLeLBFAZVszBQOgndSEhPGmFc42hfwBashqPEOMoLuYaOnlS-6xvJgXUEikeYCkzxoRARf0J2smWmnxEqNB9KbXzJtecNRSC1l3iVCu47iTZun3jNZ42VzXCPhVZO40rTDZx4TQ38H9fU6JPddth5neLlqgFvGprFwIzxhE1kelnmMaZTBBHd8YM-eVoTs53SDUG45qOoT9xL1I3rgOe_P_L5dQa9ILfXC_Il2SlWpX4FInQhX1f4_QNYY8QQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endothelium-Derived+5-Methoxytryptophan+Is+a+Circulating+Anti-Inflammatory+Molecule+That+Blocks+Systemic+Inflammation&rft.jtitle=Circulation+research&rft.au=Wang%2C+Yi-Fu&rft.au=Hsu%2C+Yu-Juei&rft.au=Wu%2C+Hsu-Feng&rft.au=Lee%2C+Guan-Lin&rft.date=2016-07-08&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0009-7330&rft.volume=119&rft.issue=2&rft.spage=222&rft.epage=236&rft_id=info:doi/10.1161%2FCIRCRESAHA.116.308559&rft.externalDocID=10.1161%2FCIRCRESAHA.116.308559
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon